Effects of nitric oxide donors on the afferent resting activity in the cephalopod statocyst

Nitric oxide (NO) plays diverse roles in the growth and development of plants and in their responses to various abiotic and biotic stresses. It has also been reported to repress flowering in Arabidopsis thaliana. In the present study, NO donors sodium nitroprusside (SNP), S-nitroso-N-acetyl penicillamine (SNAP), and 3-morpholinosydnonimine (SIN-1) induced flowering in Lemna aequinoctialis 6746 (a short-day strain) and in L. aequinoctialis LP6 (a photoperiod-insensitive strain) under noninductive conditions. Nitrate and nitrite, two stable metabolites of NO, did not induce flowering. On the other hand, cyanide donors potassium ferricyanide {K3[Fe(CN)6]} and potassium cyanide (KCN) induced flowering in both strains under noninductive conditions. The flowering induced under a 8-h daily photoperiod regime in the short-day strain L. aequinoctialis 6746 was inhibited by NO and cyanide donors. Vegetative multiplication of both strains was adversely affected by NO and cyanide donors, irrespective of the photoperiod conditions. The observed effects of NO donors on flowering were substantially negated by NO scavengers c-PTIO [2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide] and methylene blue. This confirmed the role of NO in induction of flowering. The inductive effect of CN− also appeared to be partly mediated through NO as NO scavengers partially negated the effect of CN−.

Simple SummaryNitric oxide (NO) plays an important role in every biological system as a gaseous hormone. NO is generated from arginine by NO synthase (NOS). NOS is inhibited by several arginine analogs, including NG-nitro-L-arginine methyl ester (L-NAME). NO is an important regulator of feeding behavior by suppressing feed intake (FI) as a result of modulating the appetite center through intracerebroventricular and intraperitoneal applications of NOS inhibitors. Feeding behavior can be regulated by peripheral systems. However, the effects of dietary NO donors and inhibitors on feeding behavior and performance are unknown. In this study, the aim was to evaluate the effects of dietary supplementation of sodium nitroprusside (SNP), an NO donor, and L-NAME, an NOS inhibitor, on performance and immunity. SNP suppressed FI and body weight gain in a dose-dependent manner throughout the study, especially in the initial period, and worsened the feed conversion ratio (FCR). L-NAME (100 mg/kg) increased FI and suppressed antibody titers, and L-NAME (25 mg/kg) improved the FCR in the initial period. Therefore, when formulating broiler starter diets, it is important to consider how diet composition will affect the NO metabolism, which is thought to have important effects on performance and immunity.This study was conducted to determine the effects of dietary supplementation of sodium nitroprusside (SNP), a nitric oxide (NO) donor, and NG-nitro-L-arginine methyl ester (L-NAME), an NO synthase inhibitor, on growth performance, organ development, and immunity in broilers. A total of 560 one-day-old mixed-gender broiler chickens (ROSS 308) were divided into one control and seven experimental groups. The experimental groups were fed a basal diet supplemented with 25, 50, 100, and 200 ppm SNP, and 25, 50, and 100 ppm L-NAME in the starter and grower diets. Body weight gain increased in groups receiving 25–100 ppm L-NAME on day 21 and 100 ppm L-NAME on days 0–42. Feed intake increased in the group receiving 100 ppm L-NAME on all days. The feed conversion ratio improved in the group receiving 25 ppm L-NAME on days 0–21, whereas it worsened in groups with 100 and 200 ppm SNP on days 0–42. Serum antibody titers decreased in the 100 ppm L-NAME group on day 21. In conclusion, the supplementation of the NO synthase inhibitor L-NAME to the broilers’ diet had a positive effect on the performance parameters, whereas the NO donor SNP worsened these parameters, especially on days 0–21.

1. This study was designed to investigate the effects of the nitric oxide (NO) donors sodium nitroprusside (SNP), 3-morpholinosydnonimine (SIN-1) and S-nitroso-N-acetylpenicillamine (SNAP) on N-formyl-L-methionyl-L-leucyl-phenylalanine (fMLP, 1 x 10(-7) M)-induced human eosinophil chemotaxis, cyclic guanosine-3',5'-monophosphate (cGMP) levels, protein nitration and cytotoxicity. 2. Human eosinophils were exposed to SNP, SIN-1 and SNAP (0.001-1.0 mM) for either short (10 min) or prolonged (90 min) time periods. Exposition of eosinophils with these NO donors significantly inhibited the eosinophil chemotaxis irrespective of whether cells were exposed to these agents for 10 or 90 min. No marked differences were detected among them regarding the profile of chemotaxis inhibition. 3. Exposition of eosinophils to SNP, SIN-1 and SNAP (0.001-1.0 mM) markedly elevated the cGMP levels above basal levels, but the 90-min exposition resulted in significantly higher levels compared with the 10-min protocols (5.3+/-0.6 and 2.6+/-0.2 nM 1.5 x 10(6) cells(-1), respectively). The cGMP levels achieved with SNAP were greater than SNP and SIN-1. 4. The NO donors did not induce cell toxicity in any experimental condition used. Additionally, eosinophils exposed to SNP, SIN-1 and SNAP (1.0 mM each) either for 10 or 90 min did not show any tyrosine nitration in conditions where a strong nitration of bovine serum albumin was observed. 5. Our findings show that inhibitory effects of fMLP-induced human eosinophil chemotaxis by NO donors at short or prolonged exposition time were accompanied by significant elevations of cGMP levels. However, additional elevations of cGMP levels do not change the functional profile (chemotaxis inhibition) of stimulated eosinophils.

Nitric oxide (NO) donors, which cause delayed headaches in migraineurs, have been shown to activate central trigeminal neurons with meningeal afferent input in animal experiments. Previous reports indicate that this response may be due to up-regulation of NO-producing cells in the trigeminal brainstem. To investigate this phenomenon further, we determined nitric oxide synthase (NOS)-containing neurons in the rat spinal trigeminal nucleus (STN), the projection site of nociceptive trigeminal afferents, following infusion of the NO donor sodium nitroprusside (SNP). Barbiturate anaesthetized rats were infused intravenously with SNP (50 microg/kg) or vehicle for 20 min or 2 h, and after periods of 3-8 h fixed by perfusion. Cryostat sections of the medulla oblongata containing the caudal STN were histochemically processed for detection of nicotineamide adenine dinucleotide phosphate (NADPH)-diaphorase or immunohistochemically stained for NOS isoforms and examined by light and fluorescence microscopy. The number of neurons positive for these markers was determined. Various forms of neurons positive for NADPH-diaphorase or immunoreactive to neuronal NOS (nNOS) were found in superficial and deep laminae of the STN caudalis and around the central canal. Neurons were not immunopositive for endothelial (eNOS) or inducible (iNOS) NOS isoforms. The number of NADPH-diaphorase-positive neurons increased time dependently after SNP infusion by a factor of more than two. Likewise, the number of nNOS-immunopositive neurons was increased after SNP compared with vehicle infusion. Around the central canal the number of NADPH-diaphorase-positive neurons was slightly increased and the number of nNOS+ neurons not changed after SNP treatment. NO donors increase the number of neurons that produce NO in the STN, possibly by induction of nNOS expression. Increased NO production may facilitate neurotransmitter release and promote nociceptive transmission in the STN. This mechanism may explain the delayed increase in neuronal activity and headache after infusion of NO donors.

We studied the role of nitric oxide (NO) and extra-cellular Ca(2+) on the melanophores in Indian snakehead teleost, Channa punctatus. Increase of Ca(2+) level in the external medium causes pigment aggregation in melanophores. This pigment-aggregating effect was found to be inhibited when the external medium contained spontaneous NO donor, sodium nitro prusside (SNP) at all the levels of concentration tested. Furthermore, it has been observed that SNP keeps the pigment in dispersed state even after increasing the amount of Ca(2+). In order to test whether NO donor SNP causes dispersion of pigments or not is checked by adding the inhibitor of nitric oxide synthase, N-omega-Nitro-L-arginine (L-NNA) in the medium. It has been noted that the inhibitor L-NNA blocked the effect of NO donor SNP causing aggregation of pigments. In that way NO is inhibiting the effect of extracellular Ca(2+), keeping the pigment dispersed.

Repeated but not acute exposure with a low dose range of the nitric oxide (NO) donor sodium nitroprusside (SNP) induces anxiolytic-like behaviour in a dose-independent manner in two different rat models of anxiety

Objective To study the effects of nitric oxide (NO) donor sodium nitroprusside (SNP) on the movement of sphincter of Oddi (SO) and different potassium channels in the hypercholesterolemia (CH) rabbits.Methods A total of 24 New Zealand rabbits were divided randomly into three groups:control group (n =8),experimental group of 4-aminopyridine (4-AP,n =8) and experimental group of tetraethylammonium (TEA,n =8).The rabbits in each group were fed on high-cholesterol diet for 8 week.By using the method of the isometric tension recording,the contractile response of SO rings to 4-AP and TEA,and the relaxant effect of SNP on SO rings in all groups were measured.Results The initial contraction of the average volatility was (0.144 ± 0.004) g,the average contraction frequency was (10.8 ± 1.1)/min.SO rings showed the contractile response to the cumulation concentrations of 4-AP,and the contraction frequency was significantly reduced in 4-AP group as compared with the control group (P＜0.05).With the final concentration of 16 mmol/L 4-AP,the relaxant effect of SNP on SO rings was significantly reduced as compared with control group (P ＜ 0.05).The accumulation concentrations of TEA could significantly shrink the SO muscle.The contraction was significantly increased,and the contraction frequency was significantly decreased in TEA group as compared with the control group (P ＜ 0.05).With the final concentration of 10 mmol/L TEA,relaxant effect of SNP on SO rings was also reduced as compared with the control group (P ＜ 0.05).Conclusion The NO donor SNP may play an important role in relaxation of the SO muscle through the KV and BKCa channels. Key words: Sphincter of Oddi dysfunction; Hypercholesterolemia; Muscle tension; Potassium channels; Nitric oxide

Contrast-induced nephropathy (CIN) is associated with increased mortality and morbidity in patients undergoing coronary angiography (CAG) and percutaneous coronary intervention (PCI). We aimed to assess the latest evidence on the preventive effects of nitric oxide (NO) donors in CIN patients undergoing CAG/PCI. We conducted a comprehensive systematic review and meta-analysis of RCTs from PubMed, Web of Science, Scopus, Embase, and Cochrane searches until May 5th, 2024. Dichotomous data were pooled using risk ratio (RR), and continuous data were pooled using mean difference (MD), both with a 95% confidence interval (CI), using (R version 4.3). Our analysis included 13 RCTs encompassing 3,550 patients. NO donors were significantly associated with a decreased incidence of CIN compared to placebo either as an oral administration (RR: 0.33 with 95% CI [0.26, 0.42], P < 0.01) or IV infusions (RR: 0.56 with 95% CI [0.40, 0.78], P < 0.01). Moreover, NO donors were significantly associated with decreased serum creatinine levels compared to placebo either as an oral administration (MD: - 0.07 with 95% CI [- 0.10, - 0.04], P < 0.01) or IV infusions (MD: - 0.07 with 95% CI [- 0.09, - 0.04], P < 0.01). In terms of safety, NO donors were significantly associated with a decreased incidence of major adverse cardiac events (MACE) compared to placebo as an oral administration (RR: 0.64 with 95% CI [0.45, 0.89], P < 0.01). However, there was no significant difference between NO donors as IV infusions and placebo in MACE (RR: 0.68 with 95% CI [0.38, 1.21], P = 0.18). Finally, NO donors were significantly associated with a decreased incidence of all-cause mortality compared to placebo as an oral administration (RR: 0.58 with 95% CI [0.36, 0.94], P = 0.03). Nevertheless, there was no statistically significant difference in all-cause mortality between IV infusions of NO donors and placebo (RR: 1.84 with 95% CI [0.40, 8.52], P = 0.44). NO donors as adjunct therapy are associated with reduced incidence of CIN and decreased serum creatinine levels, either as an oral or IV administration. They were also associated with reduced incidence of MACE, all-cause mortality, and recurrent myocardial infarction as an oral administration, which makes this simple, low-cost intervention an important therapeutic option in patients undergoing CAG/PCI.

Background: Contrast-induced nephropathy (CIN) is associated with increased mortality and morbidity in patients undergoing coronary angiography (CAG) and percutaneous coronary intervention (PCI). We aimed to assess the latest evidence on the preventive effects of nitric oxide (NO) donors in CIN in patients undergoing CAG/PCI. Methods: We conducted a systematic review and meta-analysis of RCTs from PubMed, Web of Science, Scopus, Embase, and Cochrane searches until May 5th, 2024. Dichotomous data were pooled using risk ratio (RR), and continuous data were pooled using mean difference (MD), both with a 95% confidence interval (CI), using (R version 4.3). Results: Our analysis included 13 RCTs encompassing 3,550 patients. NO donors were significantly associated with a decreased incidence of CIN compared to placebo either as an oral administration (RR: 0.33 with 95% CI [0.26, 0.42], P&lt; 0.01) or IV infusions (RR: 0.56 with 95% CI [0.40, 0.78], P&lt; 0.01). Moreover, NO donors were significantly associated with decreased serum creatinine levels compared to placebo either as an oral administration (MD: -0.07 with 95% CI [-0.10, -0.04], P&lt; 0.01) or IV infusions (MD: -0.07 with 95% CI [-0.09, -0.04], P&lt; 0.01). In terms of safety, NO donors were significantly associated with a decreased incidence of MACE compared to placebo as an oral administration (RR: 0.64 with 95% CI [0.45, 0.89], P&lt; 0.01). However, there was no significant difference between NO donors as IV infusions and placebo in MACE (RR: 0.68 with 95% CI [0.38, 1.21], P= 0.18). Finally, NO donors were significantly associated with a decreased incidence of all-cause mortality compared to placebo as an oral administration (RR: 0.58 with 95% CI [0.36, 0.94], P= 0.03). However, there was no significant difference between NO donors as IV infusions and placebo in all-cause mortality (RR: 1.84 with 95% CI [0.40, 8.52], P= 0.44). Conclusion: NO donors as an adjunct therapy are associated with reduced incidence of CIN, and decreased serum creatinine levels either as an oral or IV administration. Also, it was associated with decreased incidence of MACE and all-cause mortality as an oral administration which make this simple low-cost intervention an important therapeutic option in patients undergoing CAG/PCI.

Photoelectron transport ability of chloroplast thylakoid membranes treated with NO donor SNP: Changes in flash oxygen evolution and chlorophyll fluorescence

AimsHeart failure (HF) is a pro-thrombotic state. Both platelet and vascular responses to nitric oxide (NO) donors are impaired in HF patients with reduced ejection fraction (HFrEF) compared with healthy volunteers (HVs) due to scavenging of NO, and possibly also reduced activity of the principal NO sensor, soluble guanylate cyclase (sGC), limiting the therapeutic potential of NO donors as anti-aggregatory agents. Previous studies have shown that nitrite inhibits platelet activation presumptively after its reduction to NO, but the mechanism(s) involved remain poorly characterized. Our aim was to compare the effects of nitrite on platelet function in HV vs. HF patients with preserved ejection fraction (HFpEF) and chronic atrial fibrillation (HFpEF–AF), vs. patients with chronic AF without HF, and to assess whether these effects occur independent of the interaction with other formed elements of blood.Methods and resultsPlatelet responses to nitrite and the NO donor sodium nitroprusside (SNP) were compared in age-matched HV controls (n = 12), HFpEF–AF patients (n = 29), and chronic AF patients (n = 8). Anti-aggregatory effects of nitrite in the presence of NO scavengers/sGC inhibitor were determined and vasodilator-stimulated phosphoprotein (VASP) phosphorylation was assessed using western blotting. In HV and chronic AF, both nitrite and SNP inhibited platelet aggregation in a concentration-dependent manner. Inhibition of platelet aggregation by the NO donor SNP was impaired in HFpEF-AF patients compared with healthy and chronic AF individuals, but there was no impairment of the anti-aggregatory effects of nitrite. Nitrite circumvented platelet NO resistance independently of other blood cells by directly activating sGC and phosphorylating VASP.ConclusionWe here show for the first time that HFpEF-AF (but not chronic AF without HF) is associated with marked impairment of platelet NO responses due to sGC dysfunction and nitrite circumvents the ‘platelet NO resistance’ phenomenon in human HFpEF, at least partly, by acting as a direct sGC activator independent of NO.

Effects of low doses of different nitric oxide (NO) donors in rat models of obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD)

Nitric oxide as a signaling molecule in the cardiovascular system

Prolonged use of nitric oxide donor sodium nitroprusside induces ocular hypertension in mice

Effects of nitric oxide donors on basal and K +-evoked release of [formula omitted]noradrenaline from rat cerebral cortex synaptosomes